Oral Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome

PURPOSE: Efficacy and toxicity profile of orally administered clofarabine were evaluated in patients with higher-risk myelodysplastic syndrome (MDS). PATIENTS AND METHODS: Thirty-two patients were treated, of whom 22 had intermediate-2 or high-risk disease (International Prognostic Scoring System)....

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Clin Oncol
Κύριοι συγγραφείς: Faderl, Stefan, Garcia-Manero, Guillermo, Estrov, Zeev, Ravandi, Farhad, Borthakur, Gautam, Cortes, Jorge E., O'Brien, Susan, Gandhi, Varsha, Plunkett, William, Byrd, Anna, Kwari, Monica, Kantarjian, Hagop M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: American Society of Clinical Oncology 2010
Θέματα:
ORIGINAL REPORTS
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872315/
https://ncbi.nlm.nih.gov/pubmed/20421540
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.3509
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια